Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis' Kisqali CHMP Nod In Fast-Moving Market

Jun 23 2017

• By Alexandra Shimmings

Breast Cancer Awareness: Microscopic image (photomicrograph) of core biopsy for infiltrating (invasive) ductal carcinoma, detected by screening mammogram. H & E stain. — • Source: Shutterstock

Related Content

Novartis Sets 'Flexible Pricing' For Kisqali To Compete Against Pfizer's Ibrance

Mar 14 2017

ASCO Upsets CDK4/6 Class: Strong Data For Lilly's Abemaciclib, But Pfizer's Ibrance Disappoints

Jun 08 2017

Pfizer To Compromise On NICE Price For Ibrance?

Feb 02 2017

Related Companies

Novartis AG

AstraZeneca PLC

Eli Lilly and Company

Additional Topics

Approvals Companies Cancer BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window